Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre
This multicenter retrospective cohort study analyzed 611 patients who remained cancer-free for at least two years following treatment for histologically confirmed small-cell lung cancer (SCLC). The study assessed the incidence of second primary cancers (SPCs) in this population. Findings revealed that the overall risk of SPCs was 3.5 times higher